Suppr超能文献

相似文献

1
Optic neuropathy secondary to perhexiline and amiodarone.
BMJ Case Rep. 2021 Jan 27;14(1):e237727. doi: 10.1136/bcr-2020-237727.
2
A case series of concomitant treatment of perhexiline with amiodarone.
Ther Drug Monit. 2012 Apr;34(2):227-31. doi: 10.1097/FTD.0b013e318245e5a6.
3
Amiodarone induced optic neuropathy.
Br J Ophthalmol. 2003 Apr;87(4):420-2. doi: 10.1136/bjo.87.4.420.
4
Optic neuropathy in patients using amiodarone.
Arch Ophthalmol. 2006 May;124(5):696-701. doi: 10.1001/archopht.124.5.696.
5
Two cases of bilateral amiodarone-associated optic neuropathy.
J Fr Ophtalmol. 2014 Mar;37(3):231-6. doi: 10.1016/j.jfo.2013.12.004. Epub 2014 Feb 24.
7
Features of amiodarone-induced optic neuropathy.
Am J Ophthalmol. 1999 May;127(5):610-2. doi: 10.1016/s0002-9394(99)00016-1.
8
9
Amiodarone optic neuropathy without disc edema.
J Neuroophthalmol. 2000 Sep;20(3):171-2. doi: 10.1097/00041327-200020030-00007.
10
Bilateral optic neuropathy and permanent loss of vision after treatment with amiodarone.
J Cardiovasc Pharmacol. 2013 Oct;62(4):394-6. doi: 10.1097/FJC.0b013e31829f9e40.

引用本文的文献

1
Amiodarone-related keratopathy and optic neuropathy: case report and literature review.
Front Med (Lausanne). 2025 Apr 2;12:1572461. doi: 10.3389/fmed.2025.1572461. eCollection 2025.
2
Non-arteritic anterior ischemic optic neuropathy secondary to Posner-Schlossman syndrome in a twenty-six-year-old female.
Am J Ophthalmol Case Rep. 2023 Feb 14;30:101816. doi: 10.1016/j.ajoc.2023.101816. eCollection 2023 Jun.
3
Risk Factors of Eye Complications in Patients Treated in the Intensive Care Unit.
Int J Environ Res Public Health. 2021 Oct 25;18(21):11178. doi: 10.3390/ijerph182111178.

本文引用的文献

1
Amiodarone-Associated Optic Neuropathy: Clinical Review.
Neuroophthalmology. 2016 Nov 18;41(2):55-58. doi: 10.1080/01658107.2016.1247461. eCollection 2017 Apr.
2
Mitochondrial disorders with significant ophthalmic manifestations.
Middle East Afr J Ophthalmol. 2008 Apr;15(2):81-6. doi: 10.4103/0974-9233.51998.
3
Perhexiline.
Cardiovasc Drug Rev. 2007 Spring;25(1):76-97. doi: 10.1111/j.1527-3466.2007.00006.x.
4
CSF opening pressure: reference interval and the effect of body mass index.
Neurology. 2006 Nov 14;67(9):1690-1. doi: 10.1212/01.wnl.0000242704.60275.e9.
5
Amiodarone and reversible benign intracranial hypertension.
Cardiology. 1996 Jan-Feb;87(1):90. doi: 10.1159/000177068.
6
Pseudotumor cerebri as a complication of amiodarone therapy.
Am J Ophthalmol. 1993 Dec 15;116(6):776-7. doi: 10.1016/s0002-9394(14)73487-7.
8
Is perhexiline essential for the optimal management of angina pectoris?
Aust N Z J Med. 1995 Apr;25(2):111-3. doi: 10.1111/j.1445-5994.1995.tb02820.x.
9
Severe ocular side effects of perhexilene maleate: case report.
Br J Ophthalmol. 1984 Aug;68(8):553-60. doi: 10.1136/bjo.68.8.553.
10
Acute intracranial hypertension during amiodarone infusion.
Crit Care Med. 1985 Aug;13(8):688-9. doi: 10.1097/00003246-198508000-00018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验